婚姻生活 发表于 2025-3-23 10:26:37
http://reply.papertrans.cn/47/4625/462444/462444_11.pngCriteria 发表于 2025-3-23 17:10:09
http://reply.papertrans.cn/47/4625/462444/462444_12.png复习 发表于 2025-3-23 18:23:26
here review the design and endpoint selection for clinical trials of nOH in patients with Parkinson disease and other synucleinopathies, recapitulate the results of completed and ongoing clinical trials for nOH, and discuss common challenges and their potential remedies.Wallow 发表于 2025-3-24 00:07:08
http://reply.papertrans.cn/47/4625/462444/462444_14.pngblackout 发表于 2025-3-24 03:58:52
http://reply.papertrans.cn/47/4625/462444/462444_15.pngAsseverate 发表于 2025-3-24 08:47:13
http://reply.papertrans.cn/47/4625/462444/462444_16.png占卜者 发表于 2025-3-24 13:20:18
Ahmad Rashiq,Om Prakashnic health records or claims data representing active surveillance..Pharmacovigilance has contributed substantially to our knowledge of the safety of antiparkinsonian drugs. Though patients on dopamine agonists and/or L-DOPA usually develop diurnal somnolence or impulse-control disorders, because thGanglion 发表于 2025-3-24 18:01:18
Shweta Bhardwaj,Ramesh Veerappanments. Models based on paraquat and rotenone are appealing for their relevance to some well-known environmental risk factors of the human PD, although they yield only partial dopaminergic degeneration and entail a considerable risk of nonspecific toxicity. The main general limitation of neurotoxin-bnephritis 发表于 2025-3-24 19:15:20
http://reply.papertrans.cn/47/4625/462444/462444_19.pngamyloid 发表于 2025-3-25 00:21:57
http://reply.papertrans.cn/47/4625/462444/462444_20.png